Angewandte
Chemie
Chem. 1996, 108, 2726 – 2748; Angew. Chem. Int. Ed. Engl. 1996,
35, 2566 – 2587.
approach provides a novel route to enantioenriched amine
derivatives. We anticipate that, for a range of chiral Brønsted
acid catalyzed (as opposed to nucleophile-catalyzed) process-
es, these new planar-chiral pyridines may prove to be more
useful than their DMAP-derived relatives.
[4] For leading references on the chemistry of acyl azides, see:
a) H. W. Moore, D. M. Goldish in The Chemistry of Halides,
Pseudo-Halides, and Azides, Vol. 1 (Eds.: S. Patai, Z. Rappoport,
Wiley, New York, 1983, pp. 321 – 368; b) W. Lwowski in Azides
and Nitrenes (Ed.: E. F. V. Scriven), Academic, New York, 1984,
pp. 205 – 246.
Received: February 14, 2007
Published online: April 30, 2007
[5] For an overview of the chemistry of ketenes, see: T. T. Tidwell,
Ketenes, Wiley-Interscience, New York, 2006.
[6] For examples of other catalytic asymmetric reactions of HN3,
see: a) M. S. Taylor, D. N. Zalatan, A. M. Lerchner, E. N.
Jacobsen, J. Am. Chem. Soc. 2005, 127, 1313 – 1317; b) J. K.
Myers, E. N. Jacobsen, J. Am. Chem. Soc. 1999, 121, 8959 – 8960.
[7] For a discussion of the chemistry of HN3, including its toxicity,
see: G. W. Breton, P. J. Kropp in Encyclopedia of Reagents for
Organic Synthesis (Ed.: L. A. Paquette), Wiley, New York, 1995,
pp. 2685 – 2688.
Keywords: amines · asymmetric catalysis ·
homogeneous catalysis · ketenes · rearrangement
.
[1] a) S. L. Wiskur, G. C. Fu, J. Am. Chem. Soc. 2005, 127, 6176 –
6177; b) B. L. Hodous, G. C. Fu, J. Am. Chem. Soc. 2002, 124,
10006 – 10007; c) C. Schaefer, G. C. Fu, Angew. Chem. 2005, 117,
4682 – 4684; Angew. Chem. Int. Ed. 2005, 44, 4606 – 4608.
[8] For leading references to the synthesis and use of chiral amines,
see: a) A. Johansson, Contemp. Org. Synth. 1995, 2, 393 – 407;
b) Journal: Biogenic Amines (Brill: Leiden, Netherlands).
[9] For examples of the use and biological activity of enantiopure a-
aryl amines, see: a) E. Juaristi, J. L. Leon-Romo, A. Reyes, J.
Escalante, Tetrahedron: Asymmetry 1999, 10, 2441 – 2495; b) V.
Kumar, R. Lane in Research and Practice in Alzheimerꢀs Disease,
Springer, New York, 2003, pp. 242 – 249.
[10] Consistent with expectations, it is advantageous to add the HN3
by syringe pump over 1–2 h, rather than all at once.
[11] In contrast, under our standard reaction conditions, HN3 does
not add to phenyl isopropyl ketene at an appreciable rate in the
absence of a catalyst.
[2] For reviews, see: a) T. Akiyama, J. Itoh, K. Fuchibe, Adv. Synth.
Catal. 2006, 348, 999 – 1010; b) C. Bolm, T. Rantanen, I.
Schiffers, L. Zani, Angew. Chem. 2005, 117, 1788 – 1793;
Angew. Chem. Int. Ed. 2005, 44, 1758 – 1763.
[3] For reviews of enantioselective protonation reactions of enols/
enolates, see: a) A. Yanagisawa in Comprehensive Asymmetric
Catalysis (Supplement 2); (Eds.: E. N. Jacobsen, A. Pfaltz, H.
Yamamoto), Springer, New York, 2004, pp. 125 – 132; b) A.
Yanagisawa, H. Yamamoto in Comprehensive Asymmetric
Catalysis (Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto),
Springer, New York, 1999, chap. 34.2; c) J. Eames, N. Weera-
sooriya, Tetrahedron: Asymmetry 2001, 12, 1 – 24; d) C. Fehr in
Chirality in Industry II (Eds.: A. N. Collins, G. N. Sheldrake, J.
Crosby), Wiley, New York, 1997, chap. 16; e) C. Fehr, Angew.
[12] For an additional discussion, see reference [1].
Angew. Chem. Int. Ed. 2007, 46, 4367 –4369
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim